Moderna criticized for COVID-19 vaccine strategy putting once feel-good success story in jeopardy kdunleavy Wed, 10/13/2021 – 10:58 More: Moderna criticized for COVID-19 vaccine strategy putting once feel-good success story in jeopardy Source: fierce
read moreJohnson & Johnson, Moderna COVID-19 vaccines work as intended, FDA staff say ahead of high-stakes booster meeting esagonowsky Wed, 10/13/2021 – 10:40 More: Johnson & Johnson, Moderna COVID-19 vaccines work as intended, FDA staff say ahead of high-stakes booster meeting
read moreECTRIMS: Roche touts 8-year Ocrevus data to defend multiple sclerosis leadership aliu Wed, 10/13/2021 – 10:11 More: ECTRIMS: Roche touts 8-year Ocrevus data to defend multiple sclerosis leadership Source: fierce
read moreArdelyx axes 65% of workforce with no clarity from FDA on kidney drug’s future klahucik Wed, 10/13/2021 – 09:36 More: Ardelyx axes 65% of workforce with no clarity from FDA on kidney drug's future Source: fierce
read moreFDA Form 483 puts a wrinkle into Revance’s application for Botox rival jkeenan Wed, 10/13/2021 – 09:31 More: FDA Form 483 puts a wrinkle into Revance's application for Botox rival Source: fierce
read moreIn a Phase III study, the risk of death for advanced RCC patients was decreased by 34% with Cabometyx plus Opdivo treatment More: SMC accepts Cabometyx/Opdivo combo for advanced kidney cancer patients Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals